J.W. Cole Advisors, Inc. Eli Lilly & CO Transaction History

J.W. Cole Advisors, Inc.

$2.33 Billion
Q3 2024

A detailed history of J.W. Cole Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 9,548 shares of LLY stock, worth $7.19 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

9,548

Previous 9,343 2.19%

Holding current value

$7.19 Million

Previous $8.46 Million -0.0%

% of portfolio

0.36%

Previous 0.4%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $158,288 - $196,804	205 Added 2.19%	9,548 $8.46 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $113,804 - $142,719	157 Added 1.71%	9,343 $8.46 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $76,986 - $102,996	130 Added 1.44%	9,186 $7.15 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $215,327 - $253,843	-410 Reduced 4.33%	9,056 $5.28 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $212,133 - $292,458	-488 Reduced 4.9%	9,466 $5.08 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $800,739 - $1.07 Million	-2,283 Reduced 18.66%	9,954 $4.67 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $1.49 Million - $1.74 Million	4,781 Added 64.12%	12,237 $4.2 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $48,875 - $56,949	-152 Reduced 2.0%	7,456 $2.73 Million
Q3 2022 Oct 31, 2022	BUY	$296.48 - $337.87 $249,636 - $284,486	842 Added 12.44%	7,608 $2.46 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $129,609 - $152,180	465 Added 7.38%	6,766 $2.19 Million
Q1 2022 Jun 10, 2022	SELL	$234.69 - $291.66 $295 Million - $366 Million	-1,254,855 Reduced 99.5%	6,301 $1.8 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $295 Million - $366 Million	1,255,777 Added 23345.92%	1,261,156 $611,000
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $63,407 - $78,689	282 Added 5.53%	5,379 $1.49 Million
Q3 2021 Oct 26, 2021	BUY	$221.6 - $272.71 $91,077 - $112,083	411 Added 8.77%	5,097 $1.18 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $65,720 - $85,008	364 Added 8.42%	4,686 $1.08 Million
Q1 2021 Apr 28, 2021	BUY	$164.32 - $212.72 $171,878 - $222,505	1,046 Added 31.93%	4,322 $807,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $1.13 Million - $1.49 Million	-8,626 Reduced 72.48%	3,276 $553,000
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $1.74 Million - $2.01 Million	11,902 New	11,902 $1.76 Million
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $372,388 - $460,910	-3,128 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$106.92 - $132.43 $334,445 - $414,241	3,128 New	3,128 $411,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Eli Lilly & CO Transaction History